That's a little over 132x more expensive. Compared to other common medicines like ibuprofen ($0.04 in the developing world, $0.05 in the USA [2]), what makes chloroquine so uniquely pricey in the USA? (or, I suppose, ibuprofen so uniquely cheap?)
That's a little over 132x more expensive. Compared to other common medicines like ibuprofen ($0.04 in the developing world, $0.05 in the USA [2]), what makes chloroquine so uniquely pricey in the USA? (or, I suppose, ibuprofen so uniquely cheap?)
Chloroquine exists in a walled garden where pharmaceutical companies and the government have rigged it so that rent-seeking behavior is the optimal financial strategy.
Does anyone know if there's a lot of supply in hand and if it can be made in large quantities fast?
"FDA cannot assure the safety and efficacy of unapproved drugs" is the main excuse used in drug importation court cases.
Reference: https://www.pharmacycheckerblog.com/online-pharmacies-person...
France has stopped over-the-counter sales of Ibuprofen as of mid January.
https://www.afrinik.com/anti-inflammatory-drugs-can-make-cor...
"This speculation about the safety of ACE-i or ARB treatment in relation to COVID-19 does not have a sound scientific basis or evidence to support it. Indeed, there is evidence from studies in animals suggesting that these medications might be rather protective against serious lung complications in patients with COVID-19 infection, but to date there is no data in humans.
The Council on Hypertension of the European Society of Cardiology wish to highlight the lack of any evidence supporting harmful effect of ACE-I and ARB in the context of the pandemic COVID-19 outbreak.
The Council on Hypertension strongly recommend that physicians and patients should continue treatment with their usual anti-hypertensive therapy because there is no clinical or scientific evidence to suggest that treatment with ACEi or ARBs should be discontinued because of the Covid-19 infection. " [1]
There are also the brilliant MedCram updates, where the issue of ace inhibitors et. al just happened to be discussed yesterday. In it he describes the mechanics of ACE-i and ARB treatment: https://www.youtube.com/watch?v=1vZDVbqRhyM
[1] https://www.escardio.org/Councils/Council-on-Hypertension-(C...
https://www.theguardian.com/world/2020/mar/16/health-experts...
https://www.thelancet.com/journals/lanres/article/PIIS2213-2...
But based on what we're seeing so far, it seems plausible that this virus prefers cooler northern climates. So hopefully it will turn out to be an unnecessary precaution.
The Ebola virus " spreads to people initially through direct contact with the blood, body fluids and tissues of animals. Ebola virus then spreads to other people through direct contact with body fluids of a person who is sick with or has died from EVD". [0]
This thing is in the early stages still and there are already 7x more recorded cases than the largest Ebola outbreak.
https://www.civitatis.com/en/nairobi/
Compare:
Largest cities in Africa
https://en.wikipedia.org/wiki/List_of_cities_in_Africa_by_po...
Vs
Largest cities in USA
https://en.wikipedia.org/wiki/List_of_United_States_cities_b...
https://www.forbes.com/sites/abrambrown/2020/03/16/the-priva...
Certainly not the best citation, and I have no idea where GS gets their analyses, but seems plausible enough that I'm at least hoping there could be some truth to it. See e.g. India, the virus doesn't seem to have taken off there despite a few early cases.
If it's wrong, I fear things could get really bad, especially in heavily populated cities like Lagos.
https://drive.google.com/file/d/1DqfSnlaW6N3GBc5YKyBOCGPfdqO...
Weather: Maybe 10 oF increases the doubling time 2x (steady-state reduction in exterior virus levels by 50% per Pubmed 22312351, plus reducing time × concentration of people indoors).
I don't think a paper about SARS-CoV-2 and temperature has been written yet (that I've seen), but people are hoping it reacts like SARS-CoV. See here: https://www.ncbi.nlm.nih.gov/pubmed/22312351
Keep in mind, that doesn't mean zero cases in hot weather, just that it is less contagious.
Iirc, Maylasia has a pretty strong breakout on its hands. They recorded their first death today and are at something like 670 cases. I think their double rate was 2-3 days. Edit-it’s 1 day today. See link. Not good news I think for the hypothesis.
Wuhan has temps around 50F-75F (~15C-22C). Certainty not hot, but not a cooler climate given how it's still winter in this hemisphere.
Italy and Spain aren't known for being especially cold either, mountainous areas notwithstanding.
To an extent that the French govt has officially released it as a statement. https://edition.cnn.com/2020/03/16/health/coronavirus-ibupro...
USA is famous for very high prices of essential medicines, and being an expensive country in general.
America doesn't have a lot of opportunities for foreign players, let alone in such militantly overregulated sector like medicines.
FDA rules make it expensive to start new production or enter from abroad, so a new manufacturer is in for as price war they will probably lose.
There are lots of super cheap prescription meds. Many for a penny a dose wholesale. They have robust competition but still make money at that price point, although some makers may be selling fraudulent drugs.
In theory, when the patent on a popular medication is over, new players should pull the price down to marginal cost. These days that is not happening for many products and I’d like to know why. Any economists know?